Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...
The researchers suggest certain refinements to the 2022 European LeukemiaNet classification model for patients aged 60 years ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
The interplay among genetics, social factors, cancer risk, and outcomes has been a focus of recent oncology research ... of ...
News Medical on MSN4d
Innovative triplet therapy shows encouraging results in advanced chronic myeloid leukemiaAccording to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
News Medical on MSN10d
$1.2 million NIH grant may help unravel the interplay between Down syndrome and myeloid leukemiaA four-year, $1.2 million grant from the National Cancer Institute of the National Institutes of Health may help researchers ...
There are several types of leukemia, categorized by the speed of progression (acute or chronic) and the type of blood cell affected (lymphocytic or myeloid). The four main types are: Symptoms of ...
Working to drive significant value creation with INB-100 for AML; ongoing trial is actively enrolling additional ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback